Results: 1-5 |
Results: 5

Authors: Kanzawa, F Koizumi, F Koh, Y Nakamura, T Tatsumi, Y Fukumoto, H Saijo, N Yoshioka, T Nishio, K
Citation: F. Kanzawa et al., In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction, CLIN CANC R, 7(1), 2001, pp. 202-209

Authors: Nishio, K Nakamura, T Koh, Y Kanzawa, F Tamura, T Saijo, N
Citation: K. Nishio et al., Oncoprotein 18 overexpression Increases the sensitivity to vindesine in the Human hung Carcinoma Cells, CANCER, 91(8), 2001, pp. 1494-1499

Authors: Kanzawa, F Nishio, K Fukuoka, K Sunami, T Saijo, N
Citation: F. Kanzawa et al., In vitro interactions of a new derivative of spicamycin, KRN5500, and other anticancer drugs using a three-dimensional model, CANC CHEMOT, 43(5), 1999, pp. 353-363

Authors: Sunami, T Nishio, K Kanzawa, F Fukuoka, K Kudoh, S Yoshikawa, J Saijo, N
Citation: T. Sunami et al., Combination effects of TAS-103, a novel dual topoisomerase I and II inhibitor, with other anticancer agents on human small cell lung cancer cells, CANC CHEMOT, 43(5), 1999, pp. 394-401

Authors: Fukumoto, H Tamura, T Kamiya, Y Usuda, J Suzuki, T Kanzawa, F Kuh, HJ Ohe, Y Saijo, N Nishio, K
Citation: H. Fukumoto et al., Activation-induced apoptosis of peripheral lymphocytes treated with 7-hydroxystaurosporine, UCN-01, INV NEW DR, 17(4), 1999, pp. 335-341
Risultati: 1-5 |